Breaking News, Collaborations & Alliances

Ori Biotech, Fresenius Kabi Partner to Advance Modular Manufacture of CGTs

Integration of Ori's IRO Platform with Cue and Lovo processing systems aims to enhance efficiency in CGT manufacturing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Ori Biotech Ltd., a cell and gene therapy (CGT) manufacturing technology provider, and Fresenius Kabi, entered a collaboration to integrate the IRO platform with Fresenius Kabi’s upstream and downstream processing technologies. Through this partnership, Ori and Fresenius Kabi demonstrated that IRO can be easily and effectively integrated with the Cue and Lovo Cell Processing Systems to deliver an efficient and closed workflow.   The Ori team has shown direct upstream and downstream processing ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters